UNCY — Unicycive Therapeutics Balance Sheet
0.000.00%
HealthcareMicro Cap
- $34.27m
- $31.53m
- $0.68m
Annual balance sheet for Unicycive Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.015 | 0 | 16.6 | 0.455 | 9.7 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.019 | 0.204 | 18.4 | 2.64 | 13.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | 0.333 | 0.174 | 0.792 |
Total Assets | 0.019 | 0.204 | 18.7 | 2.82 | 14.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.903 | 2.88 | 2.1 | 3.28 | 17.5 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.903 | 2.88 | 2.26 | 3.28 | 18 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.884 | -2.67 | 16.5 | -0.466 | -3.81 |
Total Liabilities & Shareholders' Equity | 0.019 | 0.204 | 18.7 | 2.82 | 14.2 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |